Showing results (31-40 of 353) with videos related to

Sort By:
Pageof 36
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 21, 2020
Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasiaT Vuorela, Harri Mustonen, Arto Kokkola, et al.
Plos One|July 18, 2019
Toll-like receptor 1 predicts favorable prognosis in pancreatic cancerMira Lanki, Hanna Seppänen, Harri Mustonen, et al.
Oncology|May 12, 2005
Syndecan-1 expression--a novel prognostic marker in pancreatic cancerAnne Juuti, Stig Nordling, Johan Lundin, et al.
Cancer Biology & Therapy|December 10, 2015
Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancerKaisa Ahopelto, Camilla Böckelman, Jaana Hagström, et al.
Cancer Medicine|May 21, 2026
Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal AdenocarcinomaNora Mattila, Riitta Lassila, Harri Mustonen, et al.
Oncology|April 18, 2012
Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancerSelja Koskensalo, Jaana Hagström, Johanna Louhimo, et al.
Anticancer Research|August 10, 2002
Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignanciesJohanna Louhimo, Patrik Finne, Henrik Alfthan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2006
Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancerMikael Railo, Johan Lundin, Caj Haglund, et al.
Oncology|October 2, 2004
Prognostic value of syndecan-1 expression in breast cancerMarja Leivonen, Johan Lundin, Stig Nordling, et al.
Neuroendocrinology|February 14, 2012
The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumoursJuha Jernman, Matti J Välimäki, Johanna Louhimo, et al.
Pageof 36